MDT EBITDA Growth
Medtronic · EBITDA Growth
MDT EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported8.89%period ending
MDT TTM EBITDA YoY % (31.99% → 8.89%)
Year-over-year change
High-resolution chart · PNG
MDT ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 8.8915% | |
| 5.4242% | |
| 8.1119% | |
| 10.1051% | |
| 12.8471% | |
| 12.4009% | |
| -2.8405% | |
| -2.9368% | |
| -6.291% | |
| -5.714% | |
| 2.2148% | |
| -0.8098% | |
| -1.9308% | |
| -0.9001% | |
| -0.2518% | |
| 6.1105% | |
| 16.4341% | |
| 16.6689% | |
| 41.5883% | |
| 28.3744% | |
| 10.7138% | |
| -3.6748% | |
| -34.6952% | |
| -30.1028% | |
| -26.0603% | |
| -16.0215% | |
| 1.2756% | |
| 3.7095% | |
| 9.4329% | |
| 8.4169% | |
| 12.1948% | |
| 8.2602% | |
| -0.0231% | |
| -0.4064% | |
| -2.0958% | |
| -4.3693% | |
| 0.5819% | |
| 0.8312% | |
| 15.0501% | |
| 28.1043% | |
| 42.9617% | |
| 56.5042% | |
| 44.9156% | |
| 42.059% | |
| 23.181% | |
| 10.5978% | |
| -9.1169% | |
| -17.7594% | |
| -11.8519% | |
| -9.5823% | |
| 5.9747% | |
| 12.3333% | |
| 3.1495% | |
| 3.02% | |
| 0.8005% | |
| -0.4235% | |
| 8.7556% | |
| 6.7715% | |
| -0.2661% | |
| -2.2761% | |
| -12.2532% | |
| -3.5006% | |
| 63.233% | |
| 75.8518% | |
| 122.4288% | |
| 79.6646% | |
| -31.1913% | |
| -35.8174% | |
| -47.5954% | |
| -39.4286% | |
| 4.6938% | |
| 7.6818% | |
| 8.9185% | |
| 8.297% | |
| 3.3232% | |
| 2.2416% | |
| 4.2093% | |
| 2.7289% | |
| 3.8219% | |
| 3.6311% | |
| 5.7476% | |
| 8.716% | |
| 7.5533% | |
| 9.2955% | |
| 10.1123% | |
| 9.9955% | |
| 15.3867% | |
| 16.4442% | |
| 14.5026% | |
| 16.0009% | |
| 15.0098% | |
| 17.2365% | |
| 21.9752% | |
| 23.5154% | |
| 24.7534% | |
| 21.8694% | |
| 18.9856% | |
| 13.9207% | |
| 10.1481% | |
| 10.6061% |